These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31087233)

  • 21. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
    Melhus CS; Rivard MJ
    Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
    Rodriguez M; Rogers DW
    Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial evaluation of Advanced Collapsed cone Engine dose calculations in water medium for I-125 seeds and COMS eye plaques.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Mar; 45(3):1276-1286. PubMed ID: 29383721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
    Lee YC; Lin SC; Kim Y
    Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verification of ophthalmic brachytherapy treatment planning.
    Packer K
    Australas Phys Eng Sci Med; 2001 Sep; 24(3):177-80. PubMed ID: 11764401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update of the CLRP eye plaque brachytherapy database for photon-emitting sources.
    Safigholi H; Parsons Z; Deering SG; Thomson RM
    Med Phys; 2021 Jun; 48(6):3373-3283. PubMed ID: 33735471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monte Carlo investigation of dose distribution of uniformly and non-uniformly loaded standard and notched eye plaques.
    Semeniuk O; Malkov V; Chamberland MJP; Weersink RA
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14149. PubMed ID: 37738654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel quality assurance system for eye plaque brachytherapy.
    Kejda A; Cutajar D; Weaver M; Petasecca M; Rosenfeld A
    Australas Phys Eng Sci Med; 2019 Dec; 42(4):1109-1115. PubMed ID: 31728937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dosimetry of 125I seed eye plaques.
    Weaver KA
    Med Phys; 1986; 13(1):78-83. PubMed ID: 3814235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Sep; 41(9):092102. PubMed ID: 25186402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
    Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
    Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
    Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
    Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying the dosimetric influences of radiation coverage and brachytherapy implant placement uncertainty on eye plaque size selection.
    Gagne NL; Rivard MJ
    Brachytherapy; 2013; 12(5):508-20. PubMed ID: 23466357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
    Bard JJ
    Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and dosimetric considerations of a modified COMS plaque: the reusable "seed-guide" insert.
    Astrahan MA; Szechter A; Finger PT
    Med Phys; 2005 Aug; 32(8):2706-16. PubMed ID: 16193802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
    Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
    Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.